Get SMART (Safe Means of Administering the Right Therapy) is organized by DKBmed. Release Date: 4/12/19 Expiration Date: 3/31/21 Each module takes 60 minutes to complete. Target Audience: This Online CME Conference is directed towards health professionals who will or have prescribed opioid analgesics in the past 12 months. There are no prerequisites. Description: Dear Colleague, Get SMART (Safe Means of Administering the Right Therapy) has been updated with new content based on the recent FDA Blueprint for pain management. This pain management curriculum now features an adaptive learning format that allows you to test-out of what you already know. Learn about the latest in pain management and earn no-cost CME! Topics include: 1. Basics of pain management 2. Pharmaceutical vs. non-pharmaceutical treatments 3. What you need to know about opioids including:       I. OUD vs. Dependence       II. Special precautions        III. Patient-provider agreements       IV. Risk calculators and other resources Earn up to 3.0 CME/CE/MOC credits (including pharmacology)! Learning Objectives: After completing this Online CME activity, the participant will demonstrate the ability to: • Assess and initiate pain management therapy. • Recognize patients with opioid use disorder. • Produce effective counselling with patients and caregivers about the safe opioid analgesics, including proper storage and disposal. • Explain the methods to modify doses and discontinue use of opioid analgesics. Visit the website   Faculty Michael R. Clark, MD, MPH, MBA Associate Professor of Psychiatry and Behavioral Health Johns Hopkins University School of Medicine Baltimore, Maryland Yvonne D'Arcy, MS, ARNP-C, CNS, FAANP Pain Management Nurse Practitioner Ponte Vedra Beach, FL

Nutrition in Dentistry, 4th ed. is organized by Hu-Friedy Mfg. Co., LLC. Last reviewed: September 1, 2019 Expires: September 1, 2022 Description: The only nutritional guide designed specifically for the dental clinician! Every chapter in this new, expertly revised full-color third edition of The Dental Hygienist's Guide to Nutritional Care relates to oral health and disease. Learn how to assess your patient's eating habits and how proper nutrition can improve both oral health and overall fitness. Case studies are used throughout to demonstrate how concepts can be applied to specific clinical situations. Nourishment for hygienists and good for dentists too: • New! Pros and cons of popular high-protein diets. • New! Nutritional value of bottled water, energy drinks, and sports drinks. • New! Ways to maintain brain health • New! Updated dietary guidelines for Americans and the USDA's MyPyramid Steps to a Healthier You This outstanding practical text also includes vitamin and mineral information organized by oral effects on soft or structural tissues; quick facts that can affect a patient's care; nutritional issues relevant to such medical issues as diabetes, obesity, and hypertension. Course 1: Essentials (Chapters 1 - 11) When you complete this course, you will take a written or online test that measures your ability to identify: • Basic concepts of nutrition and food choices. • Digestive factors and nutrients that affect the oral cavity. • The physiologic roles and best sources of carbohydrate, protein, and lipids. • Metabolic processes and their effects. • The roles of vitamins and minerals in calcified structures. • Vitamins, minerals, and fluids required for oral soft tissues and salivary glands. Course 2: Specific Applications (Chapters 12 - 20) • Nutrition and its effects on the oral health of adult females and older adults. • Nutritional requirements from infancy through adolescence for good oral health. • How nutrition and medications relate to dental caries, gingivitis, periodontal disease, and other oral cavity alterations. • Physiologic factors and systemic diseases that affect oral health. • Benefits of specific foods, vitamins, and minerals. • Factors related to nutritional assessment and counseling.

Vasculitis: Multidisciplinary Care for Multisystem Disease Online Monograph is organized by Cleveland Clinic Center for Continuing Education. Release date: September 9, 2019 Expiration date: September 9, 2021 Target Audience: The online monograph is designed for rheumatologists, nephrologists, pulmonologists, dermatologists, neurologists, and associated allied health practitioners interested in vasculitis. Accreditation: The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit. Description: Vasculitis: Multidisciplinary Care for Multisystem Disease Online Monograph will provide update on the multisystem nature of vasculitic diseases and the role of multidisciplinary collaboration in patient care. Experts from diverse medical specialties review how specific disease features can impact the approach to diagnosis and management in vasculitis. Learning Objectives: • Describe recent advances in the treatment of granulomatosis with polyangiitis and the impact of lung and kidney involvement on management • Recognize the therapeutic approaches used for asthma and other features of eosinophilic granulomatosis with polyangiitis and how to differentiate this disease from other causes of hypereosinophilia • Identify the immunosuppressive treatment options in giant cell arteritis, the role of imaging in its diagnosis and follow-up, and the spectrum of nonvasculitic disease that can affect the large vasculitic vessels • Discuss the presentation, differential diagnosis, and treatment of cutaneous vasculitis Additional details will be posted as soon as information is available.

Disease Management Clinical Decisions: Psoriasis is organized by Cleveland Clinic Foundation Center for Continuing Education. Dates: Release Date: 10/22/2019 Expiration Date: 10/22/2022 Target Audience: Directed to primary care physicians including family practitioners and internists. Accreditation: The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit. ABA MOC: This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology™ (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements. Successful completion of this activity enables the participant to earn up to 0.75 MOCA 2.0 points, points earned will be equivalent to the amount of CME credit claimed for the activity.  Please Note: It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting MOCA 2.0™ points. Maintenance of Certification in Anesthesiology™ program and MOCA® are registered trademarks of The American Board of Anesthesiology®. MOCA 2.0® is a trademark of The American Board of Anesthesiology®. Course Description: Each lesson in the Disease Management Clinical Decisions series provides a brief, case-based review of management strategies related to the topic. Questions and multiple-choice answers about the case presented include the rationale for the correct answer. Throughout this case-based lesson, you may proceed to the next question once you answer the question correctly. Learning Objectives: After completing this case the reader should be able to: • Discuss strategies for assessing psoriasis severity and its value in selecting appropriate treatment options. • Describe the relationship between psoriasis and psoriatic arthritis and the importance of screening for psoriatic arthritis in patients with psoriasis. • Recognize treat-to-target goals for patients with moderate-to-severe psoriasis. • Summarize the safety and efficacy of the various biologic classes available to treat psoriasis. • Debate the evidence linking biologic treatment with the risk of future cardiovascular events in patients with psoriasis. Additional details will be posted as soon as information is available.

CME Case Challenge: Clinical Management of CML and AML in an Era of Novel Therapies is organized by Cleveland Clinic Foundation Center for Continuing Education. Dates: Release Date: 9/11/2019 Expiration Date: 09/11/2021 Target Audience: This Online CME conference is outlined for an international audience along with the medical oncologists/hematologists, clinical and translational researchers, and other physicians and allied health care professionals treating patients with MDS and other bone marrow failure diseases. In addition, members of patient advocacy groups will benefit from this program. Accreditation: The Cleveland Clinic Foundation Center for Continuing Education assigns this abiding material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians can claim the credit commensurate based on the extent of their participation in the symposium. Participants attaining CME credit from this activity may proffer the credit hours to the American Osteopathic Association for Category 2 credit. Course Description: Clinical Management of CML and AML in an Era of Novel Therapies Online CME course will bestow an in-depth and the newest analysis of research reports associated to the biology, prognosis, natural history, and therapeutic management of patients with myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and myeloid malignancies. Learning Objectives: • Present an in-depth overview of the efficacy and side effects of combination therapies to abolish acute myeloid leukemia. • Recognize the current indications and strategies for bone marrow transplant in patients with acute myeloid leukemia or myelodysplastic syndrome. Additional details will be posted as soon as information is available.

CME Case Challenge: Clinical Management of PNH and AML in an Era of Novel Therapies is organized by Cleveland Clinic Foundation Center for Continuing Education. Conference Dates: Release Date: 9/11/2019 Expiration Date: 09/11/2021 Who should attend? This online CME conference is designed for an international audience along with the medical oncologists/hematologists, clinical and translational researchers, and other physicians and allied health care professionals treating patients with MDS and other bone marrow failure diseases. In addition, members of patient advocacy groups will serve from this program. How many credits can be obtained from CME Case Challenge: Clinical Management of PNH and AML in an Era of Novel Therapies text-based CME? Accreditation: The Cleveland Clinic Foundation Center for Continuing Education is authorized by the ACCME to present continuing medical education for physicians. The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians can acquire credit commensurate based on the extent of their participation in the activity. Participants who want to receive CME credit from this online CME course may present the credit hours to the American Osteopathic Association for Category 2 credit. What is the significance of CME Case Challenge: Clinical Management of PNH and AML in an Era of Novel Therapies text-based CME? Course Description: This online CME course will exhibit an up-to-date review of researches related to the biology, prognosis, natural history, and therapeutic management of patients with paroxysmal nocturnal hemoglobinuria (PNH) and acute myeloid leukemia (AML). What are the insights obtained from the CME Case Challenge: Clinical Management of PNH and AML in an Era of Novel Therapies text-based CME? Course Objectives: • Critically evaluate the results of research on the evolving role of chimeric antigen receptor-T cell (CAR-T) therapy in myeloid malignancies • Present an overview of the effectiveness and side effects of combinational therapies for acute myeloid leukemia • Explain the diagnostic complexities and therapy options for paroxysmal nocturnal hemoglobinuria (PNH) • Describe the genomic mutations in overlap syndromes, prognostic implications, and treatment choices • Recognize the most prevailing evidence and strategies for bone marrow transplant in patients with acute myeloid leukemia or myelodysplastic syndrome Additional details will be posted as soon as information is available.

Legal Advisor: Patient Suicidal Ideation: A Physician’s Legal Duties and Options is organized by Massachusetts Medical Society (MMS) and will be held from Mar 07, 2019 - Mar 07, 2022.  Credits: AMA Credit Designation Statement: The Massachusetts Medical Society designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for the Massachusetts Board of Registration in Medicine for risk management study. National Commission on Certification of Physicians Assistant (NCCPA): Physician Assistants may claim a maximum of 1.00 Category 1 credit for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.  Description: patients’ risk for suicide could be detected and care steps taken to save lives. While short-term suicide risk prediction is not possible, preventive care steps have been outlined as recommended practice by the National Action Alliance for Suicide Prevention as well as by The Joint Commissions (SEA 56). More often than not, legal claims in the medical malpractice world deal with alleged failures to diagnose or properly treat a type of physical condition. However, physicians are often posed with dealing with a patient's mental health just as frequently as a patient's hypertension or cardiac issues. Patients presenting with suicide risk may have psychiatric conditions that have been identified or documented by the health system or they may not. How should physicians handle statements made by patients regarding suicide? What are the liability concerns if a physician does not take the proper steps to prevent a suicide risk from becoming a reality? What if a physician takes a statement too seriously and breaches confidentiality? Is there harm from overutilizing psychiatric hospitalization. Objectives: • Describe the recommended steps and limitations of assessing a patient’s risk for suicide. • Explain why short-term prediction of the risk for suicide attempt or death is not possible with current state of science and why prevention steps are still effective and important to take. • Restate why it is imperative to thoroughly document key relevant information pertaining to suicide risk assessment and steps taken. • Consider options for clinical treatment planning, including when to hospitalize, when to refer to specialty care, and the preventive value of simply enhancing follow-up contact or communication. • Discern whether disclosure of a patient’s suicide risk to a third party is a violation of confidentiality. • Determine how to respond to a patient’s disclosure of suicidal thoughts or other indications of suicide risk in ways that help the patient and may increase the odds of the provider prevailing in any future malpractice litigation. Additional details will be posted as soon as they are available.

Clinical Decisions: Immunization in Immunocompromised Patients is organized by Cleveland Clinic Center for Continuing Education. Release Date: February 06, 2019 Expiration Date: February 06, 2022 Target Audience: Directed to primary care physicians including family practitioners and internists. Accreditation: The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Description: Each lesson in the Disease Management Clinical Decisions series provides a brief, case-based review of management strategies related to the topic. Questions and multiple-choice answers about the case presented include the rationale for the correct answer. Throughout this case-based lesson, you may proceed to the next question once you answer the question correctly. Learning Objectives: After completing this case the reader should be able to: • Critically appraise the data on the efficacy and safety of vaccinating patients with an immunocompromised condition. • Describe the effect of immunosuppressive medications on vaccine efficacy. • Differentiate between the various types of vaccines and incorporate the recommended vaccinations for patients receiving immunosuppressive medications into clinical practice. • Describe the biology, risks, and benefits of the recombinant herpes zoster vaccine.  Additional details will be posted as soon as they are available. 

The Immunologic Basis of Wellness: How personal behavior influences rheumatoid arthritis  is organized by Cleveland Clinic Center for Continuing Education. Release date: Jun 24, 2019 Expiration date: Jun 24, 2022 Target Audience: Directed to primary care physicians including family practitioners and internists. Accreditation: The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit. Description: Each lesson in the Disease Management Clinical Decisions series provides a brief, case-based review of management strategies related to the topic. Questions and multiple-choice answers about the case presented include the rationale for the correct answer. Throughout this case-based lesson, you may proceed to the next question once you answer the question correctly. Learning Objectives: After completing this case the reader should be able to: • Describe epidemiology of personal behavioral choices as risk factors for rheumatoid arthritis. • Correlate the immunopathogenesis of rheumatoid arthritis with the immunologic effects of common wellness behaviors. • Incorporate principles of wellness education in the clinical practice of rheumatology. Additional details will be posted as soon as information is available.

Abnormal Liver Enzymes is organized by Cleveland Clinic Center for Continuing Education. Release date: Jul 30, 2019 Expiration date: Jul 30, 2022 Target Audience: Directed to primary care physicians including family practitioners and internists. Accreditation: The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit. Description: Each lesson in the Disease Management Clinical Decisions series provides a brief, case-based review of management strategies related to the topic. Questions and multiple-choice answers about the case presented include the rationale for the correct answer. Throughout this case-based lesson, you may proceed to the next question once you answer the question correctly. Learning Objectives: After completing this case the reader should be able to: • Present the pros and cons of laboratory and imaging tests as screens for chronic liver disease. • Educate patients regarding the results of testing for diagnosis and prognosis of hepatitis C virus infection. • Summarize the efficacy and side effect profiles of hepatitis C virus treatments and describe potential insurance options to pay for their high cost.  Additional details will be posted as soon as information is available.